£100 million has been awarded to biotech firms across the UK to help pioneer new technologies that will help prepare for pandemics, innovate farming, and protect against floods.
The funding will be given to six new ‘Engineering Biology Mission Hubs’ and 22 ‘Mission Award’ projects across the country, that will look to build on Engineering Biology’s enormous potential to address global challenges, drive economic growth, and increase national resilience.
This announcement comes amid growing calls for the UK to prioritise science and technology.
Breakthroughs in Biotech and Cuts to Red Tape
As the department for Science and Technology marks its first anniversary, Secretary Michelle Donelan unveiled a raft of new announcements to drive innovation in science and achieve strategic advantage in all five critical technologies (AI, quantum, engineering biology, future telecoms and semiconductors).
Michelle Donelan also unveiled a package of announcements to drive further momentum behind the Department’s work including £21 million for the world-leading Biobank. The UK Biobank has been given the cash injection for a new robotic freezer, which will be used to store 20 million samples of biological data – further supporting research that is being used to treat diseases like dementia and Parkinson’s.
The Government asserts that this investment will deliver the long-term innovative change needed to deliver a brighter future for Britain and improve economic security and opportunity for everyone.
Michelle Donelan said “Long term growth is the only way we will deliver the public services and improvements in living standards that every Briton wants for themselves and their families. But as history shows, it is technological and scientific advances that are the true engine room of growth, and despite our existing strengths in these sectors, we cannot afford to pat ourselves on our back and take our eye off the ball. Cementing the UK as a Science and Technology superpower by 2030 is more than a slogan. It is a goal we must reach if we want to grow our economy, continue creating well-paid jobs and build a better, healthier, more prosperous future for the UK”.
- Announcing the winners of the Research Ventures Catalyst seed funding– with up to £100,000 available for organisations finding new and innovative ways to fund world-class R&D in the UK.
- Updating the Science and Technology Framework – outlining progress since the launch of the Framework last year – showing the government is providing record levels of funding to R&D in the UK with over £19.4 billion in the past year, supporting top researchers to spread the benefits of innovation – more jobs, opportunities, prosperity – across the country.
- Publishing two UK-led G7 papers on R&D common values and best practices – showing again the UK’s global leadership in the science and tech world and ensuring research is being conducted in a way that protects, rather than undermines, national security.
- Launching a £3 million metascience grant funding call – aimed at boosting the efficiency and effectiveness of the UK’s already world-leading research system.
- Launching an interactive innovation clusters map – offering a comprehensive picture of innovation activity in the UK aimed at helping policymakers and investors to better understand, engage with and invest in the UK’s vibrant innovation ecosystem.
The Government claims these measures will build on the record £19.4 billion invested in research and this year alone, the highest level this country has ever seen, and the nearly three quarter of a million jobs the sector has created in the last decade (a 41% increase). Statistics show that every £1 Innovate UK alone invests in grants for business innovation returns over £3.60 in direct business benefit, with a total economic return valued at over £6.20.
Curia’s Life Sciences Industrial Strategy for a New Government
Curia’s Health, Care and Life Sciences Research Group is hosting its first inquiry session supported by the NHS Innovation and Life Sciences Commission and led by Dr Keith Ridge, Professor Ann Keen and Professor Gillian Leng.
In this inquiry, our three chairs will examine the topic of ‘ A Clinically Led Approach, and Delivery with NHS Managers’, including ‘Connecting with NHS Priorities and Patient Care’ and ‘Sustainability of the NHS and Broader Impact’.
Both online and in-person attendance to the meeting will be reserved for those who have subscribed to the Health, Care and Life Sciences Research Group. Information on subscription can be found by contacting email@example.com